Categories list

Our billing is certified by: 

Secure shopping certificates
Special Offer!

Generic Urispas

Generic Urispas (Flavoxate) is an anticholinergic agent used to treat bladder or bowel spasms and in combination with other medicines to treat ulcers.

Urispas

$1.38

ADD TO CART!Add to Cart!

Generic Uroxatral

Generic UroXatral is an α1 receptor antagonist used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.

Uroxatral

$1.86

ADD TO CART!Add to Cart!

What is a generic pill?

Very often our web site visitors ask us about generic medications. In this section we have placed some useful information about generic pills in general and about the ones we have in our product list. Click here

Free

Sample

Pills

Get

Discount

Online

Live

Support

Click here to chat

News

Minacs Receives New URAC Pharmacy Benefit Management Accreditations - Sacramento Bee

Minacs Receives New URAC Pharmacy Benefit Management AccreditationsSacramento Bee20500 Minacs experts across 3 continents and 36 centers spanning Canada, Germany, Hungary, India, Jamaica, Philippines, the UK and USA power our solutions through a global delivery model that helps our clients enhance revenues, profitability and

HealthWarehouse.com Offers Consumers the Lowest Price on Generic Plavix® - Business Review USA (press release)

HealthWarehouse

News

FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.

Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years

The forming, development and monitoring of the pharmaceutical market in USA in September 2011

In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth